Institutional
TCG Crossover Management, LLC
CIK 0001839948
$3.50B
Reported AUM
49
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · TCG Crossover Management, LLC · Q1 2026
AI · grounded in 13F
TCG Crossover Management, LLC exited its position in RAPT for a reduction of $87.5M. The fund established new positions in BCRX for $104.9M, VOR for $96.5M, and DISC MEDICINE INC for $85.8M. Additionally, the manager closed its position in EYPT for $65.3M and increased its stake in MIRM by 1611.6%.
Portfolio · Q1 2026
Top holdings
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ABVX | ABIVAX SA AMERICAN DEPOSITARY SHARES | $124.33 | 4.62% | 72.81% | 1124.93% | $721.7M | 20.65% | — | HELD |
| 2 | CGON | CG ONCOLOGY INC | $73.03 | 5.66% | 168.57% | 58.04% | $248.4M | 7.11% | — | HELD |
| 3 | TNGX | TANGO THERAPEUTICS INC | $27.57 | 6.65% | 299.69% | 124.23% | $220.3M | 6.30% | — | HELD |
| 4 | COGT | COGENT BIOSCIENCES INC | $41.36 | 4.52% | 257.28% | 391.91% | $190.4M | 5.45% | — | HELD |
| 5 | CNTA | CENTESSA PHARMACEUTICALS PLC | — | — | 0.00% | — | $170.3M | 4.87% | — | HELD |
| 6 | DNTH | DIANTHUS THERAPEUTICS INC | $112.64 | 8.21% | 447.06% | 10.00% | $140.7M | 4.03% | — | HELD |
| 7 | TYRA | TYRA BIOSCIENCES INC | $33.06 | 6.27% | 209.64% | 43.41% | $124.4M | 3.56% | — | HELD |
| 8 | IMVT | IMMUNOVANT INC | $39.48 | 2.25% | 146.85% | 347.81% | $110.7M | 3.17% | — | HELD |
| 9 | BCRX | BIOCRYST PHARMACEUTICALS INC | $9.24 | -3.04% | 16.54% | -41.80% | $104.9M | 3.00% | — | HELD |
| 10 | MIRM | MIRUM PHARMACEUTICALS INC | $112.59 | 4.67% | 106.79% | 561.97% | $98.1M | 2.81% | — | HELD |
| 11 | VOR | VOR BIOPHARMA INC | $21.80 | 11.51% | -52.55% | -93.22% | $96.5M | 2.76% | — | HELD |
| 12 | SYRE | SPYRE THERAPEUTICS INC | $101.50 | 3.71% | 524.23% | -44.00% | $95.9M | 2.74% | — | HELD |
| 13 | AMLX | AMYLYX PHARMACEUTICALS INC | $20.75 | 5.17% | 151.20% | -41.09% | $86.8M | 2.48% | — | HELD |
| 14 | IRON | DISC MEDICINE INC | $79.21 | 7.52% | 34.32% | -46.33% | $85.8M | 2.45% | — | HELD |
| 15 | DYN | DYNE THERAPEUTICS INC | $25.73 | 2.51% | 150.00% | 48.41% | $83.7M | 2.39% | — | HELD |
| 16 | GLUE | MONTE ROSA THERAPEUTICS INC | $22.68 | 5.19% | 373.49% | -36.45% | $76.0M | 2.18% | — | HELD |
| 17 | SVRA | SAVARA INC | $5.54 | 4.92% | 113.90% | 257.42% | $67.5M | 1.93% | — | HELD |
| 18 | RVMD | REVOLUTION MEDICINES INC | $192.17 | 6.22% | 424.62% | 560.61% | $56.1M | 1.60% | — | HELD |
| 19 | KOD | KODIAK SCIENCES INC | $42.50 | 6.22% | 539.10% | -54.87% | $55.1M | 1.58% | — | HELD |
| 20 | LBRX | LB PHARMACEUTICALS INC | $40.90 | 4.87% | 142.26% | 152.32% | $45.3M | 1.30% | — | HELD |
| 21 | SRZN | SURROZEN INC | $20.83 | 8.49% | 89.36% | -82.15% | $42.9M | 1.23% | — | HELD |
| 22 | ADCT | ADC THERAPEUTICS SA | $1.11 | 0.91% | -58.74% | -96.19% | $42.7M | 1.22% | — | HELD |
| 23 | RLAY | RELAY THERAPEUTICS INC | $19.45 | 5.88% | 461.61% | -41.09% | $42.5M | 1.22% | — | HELD |
| 24 | FULC | FULCRUM THERAPEUTICS INC | $3.72 | 2.76% | -45.53% | -87.47% | $40.3M | 1.15% | — | HELD |
| 25 | BHVN | BIOHAVEN LTD | $13.82 | 2.90% | -6.05% | -16.60% | $39.2M | 1.12% | — | HELD |
| 26 | IPSC | CENTURY THERAPEUTICS INC | $2.19 | 8.42% | 311.65% | -91.17% | $39.0M | 1.12% | — | HELD |
| 27 | TECX | TECTONIC THERAPEUTIC INC | $28.51 | 0.28% | 37.53% | -64.33% | $37.2M | 1.07% | — | HELD |
| 28 | CATX | PERSPECTIVE THERAPEUTICS INC | $2.99 | 4.18% | -18.75% | -53.28% | $33.0M | 0.94% | — | HELD |
| 29 | XNCR | XENCOR INC | $21.49 | 10.04% | 169.30% | -36.55% | $29.6M | 0.85% | — | HELD |
| 30 | TRDA | ENTRADA THERAPEUTICS INC | $6.77 | 3.36% | 16.72% | -77.27% | $28.9M | 0.83% | — | HELD |
| 31 | ALXO | ALX ONCOLOGY HOLDINGS INC | $1.95 | 0.26% | — | — | $26.1M | 0.75% | — | HELD |
| 32 | ARVN | ARVINAS HOLDING CO LLC | $8.30 | 0.97% | — | — | $25.3M | 0.72% | — | HELD |
| 33 | JANX | JANUX THERAPEUTICS INC | $15.58 | 4.14% | — | — | $24.9M | 0.71% | — | HELD |
| 34 | AGMB | AGOMAB THERAPEUTICS NV | $12.76 | 2.90% | — | — | $21.5M | 0.62% | — | HELD |
| 35 | ALEC | ALECTOR INC | $1.62 | 6.58% | — | — | $21.5M | 0.62% | — | HELD |
| 36 | MBX | MBX BIOSCIENCES INC | $66.46 | 3.91% | — | — | $19.4M | 0.56% | — | HELD |
| 37 | SLN | SILENCE THERAPEUTICS PLC | $11.62 | 0.61% | — | — | $16.0M | 0.46% | — | HELD |
| 38 | LQDA | LIQUIDIA TECHNOLOGIES INC | $86.80 | -0.02% | — | — | $15.2M | 0.44% | — | HELD |
| 39 | OCUL | OCULAR THERAPEUTIX INC | $8.47 | 1.32% | — | — | $14.0M | 0.40% | — | HELD |
| 40 | AVTX | AVALO THERAPEUTICS INC | $19.39 | 2.00% | — | — | $11.0M | 0.32% | — | HELD |
| 41 | URGN | UROGEN PHARMA LTD | $41.09 | 1.58% | — | — | $7.3M | 0.21% | — | HELD |
| 42 | MNPR | MONOPAR THERAPEUTICS INC | $114.66 | 6.73% | — | — | $7.2M | 0.21% | — | HELD |
| 43 | CNTX | CONTEXT THERAPEUTICS INC | $0.61 | -1.62% | — | — | $7.0M | 0.20% | — | HELD |
| 44 | GPCR | STRUCTURE THERAPEUTICS INC | $49.47 | 4.48% | — | — | $6.8M | 0.19% | — | HELD |
| 45 | CGEM | CULLINAN THERAPEUTICS INC | $17.52 | 1.80% | — | — | $5.8M | 0.17% | — | HELD |
| 46 | KRRO | KORRO BIO INC | $10.45 | 3.77% | — | — | $4.7M | 0.13% | — | HELD |
| 47 | LONA | LEONABIO INC | $7.29 | 3.55% | — | — | $4.7M | 0.13% | — | HELD |
| 48 | UPB | UPSTREAM BIO INC | $6.57 | 2.50% | — | — | $1.6M | 0.05% | — | HELD |
| 49 | VTGN | VISTAGEN THERAPEUTICS INC | $0.24 | 0.00% | — | — | $1.5M | 0.04% | — | HELD |
Source: SEC EDGAR · accession 0001214659-26-006367. 13F discloses long positions only — shorts, foreign equities, and options are excluded.